Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improves outcomes (major amputation and survival) up a 5-year follow-up, but it is not known if in this length of time the survival curves, of clinical responders and non-responders, differ
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improve...
Critical limb ischemia (CLI) is the most severe manifestation of the peripheral arterial disease. To...
Critical limb ischemia (CLI) is the most severe manifestation of the peripheral arterial disease. To...
AbstractBackgroundIloprost, which has efficacy in the microvascular space, is shown to have benefici...
AIM: The aim of this study was to evaluate the capacity of transcutaneous partial pressure of O(2) (...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objective:To assess the predictivity of predefined variables with respect to long-term mortality in ...
ObjectivesTo evaluate the effects of iloprost, in addition to surgery, on the outcome of acute lower...
AbstractObjective: to assess the predictivity of clinical variables in patients with chronic critica...
BackgroundAlthough percutaneous intervention (PTA) is considered first-line therapy for peripheral v...
BackgroundAlthough percutaneous intervention (PTA) is considered first-line therapy for peripheral v...
ObjectivesTo evaluate the effects of iloprost, in addition to surgery, on the outcome of acute lower...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improve...
Critical limb ischemia (CLI) is the most severe manifestation of the peripheral arterial disease. To...
Critical limb ischemia (CLI) is the most severe manifestation of the peripheral arterial disease. To...
AbstractBackgroundIloprost, which has efficacy in the microvascular space, is shown to have benefici...
AIM: The aim of this study was to evaluate the capacity of transcutaneous partial pressure of O(2) (...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objective:To assess the predictivity of predefined variables with respect to long-term mortality in ...
ObjectivesTo evaluate the effects of iloprost, in addition to surgery, on the outcome of acute lower...
AbstractObjective: to assess the predictivity of clinical variables in patients with chronic critica...
BackgroundAlthough percutaneous intervention (PTA) is considered first-line therapy for peripheral v...
BackgroundAlthough percutaneous intervention (PTA) is considered first-line therapy for peripheral v...
ObjectivesTo evaluate the effects of iloprost, in addition to surgery, on the outcome of acute lower...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...
Objectives: To evaluate the effects of iloprost, in addition to surgery, on the outcome of acute low...